Dolfini E - Search Results

1

Molecular determinants of intrinsic resistance to doxorubicin in human cancer cell lines.

Gariboldi MB, Ravizza R, Riganti L, Meschini S, Calcabrini A, Marra M, Arancia G, Dolfini E, Monti E. Gariboldi MB, et al. Among authors: dolfini e. Int J Oncol. 2003 May;22(5):1057-64. Int J Oncol. 2003. PMID: 12684672 Free article.

2

Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.

Meschini S, Calcabrini A, Monti E, Del Bufalo D, Stringaro A, Dolfini E, Arancia G. Meschini S, et al. Among authors: dolfini e. Int J Cancer. 2000 Sep 1;87(5):615-28. Int J Cancer. 2000. PMID: 10925353

3

Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.

Dolfini E, Dasdia T, Arancia G, Molinari A, Calcabrini A, Scheper RJ, Flens MJ, Gariboldi MB, Monti E. Dolfini E, et al. Br J Cancer. 1997;76(1):67-76. doi: 10.1038/bjc.1997.338. Br J Cancer. 1997. PMID: 9218735 Free PMC article.

4

Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells.

Meschini S, Marra M, Calcabrini A, Monti E, Gariboldi M, Dolfini E, Arancia G. Meschini S, et al. Among authors: dolfini e. Toxicol In Vitro. 2002 Aug;16(4):389-98. doi: 10.1016/s0887-2333(02)00035-8. Toxicol In Vitro. 2002. PMID: 12110277

5

Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure.

La Porta CA, Dolfini E, Comolli R. La Porta CA, et al. Among authors: dolfini e. Br J Cancer. 1998 Nov;78(10):1283-7. doi: 10.1038/bjc.1998.672. Br J Cancer. 1998. PMID: 9823967 Free PMC article.

6

Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.

Jori A, Cecchetti G, Dolfini E, Monti E, Garattini S. Jori A, et al. Among authors: dolfini e. Eur J Pharmacol. 1974 Jul;27(2):245-8. doi: 10.1016/0014-2999(74)90152-6. Eur J Pharmacol. 1974. PMID: 4851685 No abstract available.

7

Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs.

Perego P, Boiardi A, Carenini N, De Cesare M, Dolfini E, Roberto-Giardini, Magnani I, Martignone S, Silvani A, Soranzo C, et al. Perego P, et al. Among authors: dolfini e. J Cancer Res Clin Oncol. 1994;120(10):585-92. doi: 10.1007/BF01212812. J Cancer Res Clin Oncol. 1994. PMID: 7929529

8

Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.

Conforti G, Codegoni AM, Scanziani E, Dolfini E, Dasdia T, Calza M, Caniatti M, Broggini M. Conforti G, et al. Among authors: dolfini e. Br J Cancer. 1995 Mar;71(3):505-11. doi: 10.1038/bjc.1995.101. Br J Cancer. 1995. PMID: 7880731 Free PMC article.

9

Analysis of calcium-dependent protein kinase-C isoenzymes in intrinsically resistant cloned lines of LoVo cells: reversal of resistance by kinase inhibitor 1-(5-isoquinolinylsulfonyl) 2-methylpiperazine.

Dolfini E, Dasdia T, Perletti G, Romagnoni M, Piccinini F. Dolfini E, et al. Anticancer Res. 1993 Jul-Aug;13(4):1123-7. Anticancer Res. 1993. PMID: 8394671

10

In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line.

Dolfini E, Elli L, Dasdia T, Bufardeci B, Colleoni MP, Costa B, Floriani I, Falini ML, Guerrieri N, Forlani F, Bardella MT. Dolfini E, et al. Toxicol In Vitro. 2002 Aug;16(4):331-7. doi: 10.1016/s0887-2333(02)00017-6. Toxicol In Vitro. 2002. PMID: 12110270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters